Safety aspects of using iodoform as a methane-mitigating feed additive to dairy cows: Impacts of milk and serum on bovine mammary and human intestinal epithelial cell lines
JDS Communications · 2026-11 · 7 (6) · 986-992
DOI: 10.3168/jdsc.2025-1048 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDS Communications, 2026-11. Verfasst von Marie Rønn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal and Veterinary Sciences, Research Centre Foulum, Aarhus University Viborg, DK-8830 Tjele, Denmark. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovationsfonden.
Abstract (Originalsprache)
Ongoing research investigates the use of bromoform and other brominated halomethanes as antimethanogenic additives for ruminant livestock. Recently, iodoform has also been shown to be a potent methane inhibitor in dairy cows. To evaluate potential associated effects of using iodoform as a feed additive, cell viability assays were conducted using 2 cell lines: bovine mammary epithelial cells (MAC-T) and human intestinal epithelial cells (FHs 74 Int.), representing mammary and intestinal epithelial cell models, respectively. Cells were cultivated in media containing 1%, 5%, or 10% (vol/vol) of milk whey or blood serum sampled from multicannulated (ruminal, duodenal, and ileal) Danish Holstein dairy cows that were dosed intraruminally daily with iodoform (0, 320, 640, and 800 mg/d). The iodoform dosages were determined based on a previous unpublished pilot study. Moreover, we also investigated the effects of the direct addition of 7 different concentrations (0.003-10 µM) of the pure compounds iodoform, diiodomethane, and iodomethane on the viability of MAC-T cells. Cell viability was increased in both MAC-T and FHs 74 Int. cell lines with increased concentration of serum or whey, whether from control (0 mg/d) or iodoform-supplemented cows. No significant linear or quadratic effects of serum or whey were observed on either cell line. Consistent with these findings, MAC-T cell viability was unaffected by exposure to iodoform or its reduced form, iodomethane, across concentrations of 0.003 to 7 µM. In contrast, diiodomethane reduced cell viability at concentrations >0.5 µM; however, these levels exceed those expected in vivo following iodoform supplementation. Overall, intraruminal administration of iodoform to dairy cows was not associated with adverse effects of serum or whey on MAC-T or FHs 74 Int. cell viability.
Autor:innen und Institutionen
- Department of Animal and Veterinary Sciences, Research Centre Foulum, Aarhus University Viborg, DK-8830 Tjele, Denmark.
- SEGES Innovation, Agro Food Park 15, DK-8200 Aarhus, Denmark.
Förderung
- Innovationsfonden
Zitieren
APA
Rønn, M., Thorsteinsson, M., Nielsen, M. O., & Purup, S. (2026). Safety aspects of using iodoform as a methane-mitigating feed additive to dairy cows: Impacts of milk and serum on bovine mammary and human intestinal epithelial cell lines. JDS Communications, 7(6), 986-992. https://doi.org/10.3168/jdsc.2025-1048
Vancouver
Rønn M, Thorsteinsson M, Nielsen MO, Purup S. Safety aspects of using iodoform as a methane-mitigating feed additive to dairy cows: Impacts of milk and serum on bovine mammary and human intestinal epithelial cell lines. JDS Communications. 2026;7(6):986-992. doi:10.3168/jdsc.2025-1048
BibTeX
@article{Rnn2026,
author = {Rønn, Marie and Thorsteinsson, Mirka and Nielsen, Mette Olaf and Purup, Stig},
title = {Safety aspects of using iodoform as a methane-mitigating feed additive to dairy cows: Impacts of milk and serum on bovine mammary and human intestinal epithelial cell lines},
journal = {JDS Communications},
year = {2026},
volume = {7},
number = {6},
pages = {986--992},
doi = {10.3168/jdsc.2025-1048}
}
EUVIMED